THQ

abrdn Healthcare Opportunities Fund (the Fund), formerly Tekla Healthcare Opportunities Fund, is a non-diversified closed-end management investment company. The Fund's investment objective is to seek current income and long-term capital appreciation through investments in United States and non-United States companies in the healthcare industry, including equity securities, debt securities and pooled investment vehicles. It invests primarily in securities of public and private companies. The Fund invests up to 20 % of managed assets, measured at the time of investment, in the debt of healthcare companies. The Fund also invests in private companies and other restricted securities, including private investments in public equity and venture capital investments. It invests in health care providers and services, pharmaceuticals, health care equipment and supplies, life sciences tools and services, biotechnology, and medical devices and diagnostics. The Fund's investment adviser is abrdn Inc.

Wall Street analysts forecast THQ stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for THQ is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

abrdn Healthcare Opportunities Fund revenue for the last quarter amounts to NaN USD, decreased % YoY.

abrdn Healthcare Opportunities Fund. EPS for the last quarter amounts to USD, decreased % YoY.

abrdn Healthcare Opportunities Fund (THQ) has 0 emplpoyees as of December 19 2025.

Today THQ has the market capitalization of 0.00 USD.